500
Participants
Start Date
June 30, 2014
Primary Completion Date
September 30, 2016
Study Completion Date
September 30, 2016
RBP-7000
"120-mg RBP-7000 dose delivered by subcutaneous injection every 28 days for a total of 13 injections (for roll-over participants, the first two injections took place under study RB-US-09-0010).~A one-time down-titration to 90 mg RBP-7000 is permitted at the investigator's discretion should the participant have tolerability issues. Participants who received the 90-mg dose of RBP-7000 and exhibited a worsening in psychiatric symptoms could receive a one-time up-titration back to 120 mg RBP-7000 at the discretion of the investigator.~RBP-7000 is a combination of the ATRIGEL Delivery System and risperidone. The ATRIGEL Delivery System allows for sustained-release of risperidone in a controlled manner."
Behavioral Medical Research of Brooklyn, Brooklyn
Comprehensive Clinical Development-Queens, Jamaica
Neurobehavioral Research, Cedarhurst
Finger Lakes Clinical Research, Rochester
CRI Lifetree - Philadelphia Unit, Philadelphia
Keystone Clinical Studies, Norristown
Berks Center for ClinicalResearch, Reading
Comprehensive Clinical Development-Washington DC, Washington D.C.
Alliance Research Group, Richmond
New Hope Clinical Research, Charlotte
Clinical Trials of America, Hickory
iResearch Atlanta, Decatur
Radiant Research, Atlanta
Florida Clinical Research Center, Maitland
Behavioral Clinical Reserach, Hollywood
Premier Clinical Resarch Institute, Miami
Innovative Clinical Research, Fort Lauderdale
Florida Clinical Research Center, Bradenton
Research Strategies of Memphis, Memphis
Insight Clinical Trials LLC, Shaker Heights
Behavioral Health Hospital, Hoffman Estates
Baber Research Group, Naperville
Uptown Research Institute, Chicago
St. Louis Clinical Trials, St Louis
Centerpointe Hospital, Saint Charles
Via Christi Research, Wichita
Lake Charles Clinical Trials, Lake Charles
Woodland International Research Group, Inc., Little Rock
Woodland Research Northwest, LLC, Springdale
Oklahoma Clinical Research Center, Oklahoma City
Cutting Edge Research Group, Oklahoma City
FutureSearch Clinical Trials, L.P., Dallas
Pillar Clinical Research, Dallas
Bayou City Research, Houston
FutureSearch Clinical Trials, Austin
Community Clinical Research, Inc., Austin
Altea Research Institute, Las Vegas
CNRI-Los Angeles, Pico Rivera
Comprehensive Clinical Development, Cerritos
Collaborative Neuroscience Network, LLC, Long Beach
Apostle Clinical Trials, Long Beach
Behavioral Research Specialists, Glendale
Synergy EPIC, Escondido
Excell Research, Oceanside
CNRI-San Diego, San Diego
Pacific Research Partners, Oakland
Research Center for Clinical Studies, Norwalk
CRI Lifetree - Marlton Unit, Marlton
Lead Sponsor
Indivior Inc.
INDUSTRY